Ionis Pharmaceuticals Inc (IONS) stock
IONSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/302% below fair value
$27.39+0.43 (+1.59%)
Close on Nov 18, 2026Market cap $4.55BP/E –Yield –
Ionis Pharmaceuticals operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Ionis Pharmaceuticals's operating cash flow for the twelve months ending Jun 30, 2026 was -$496.43M. For fiscal 2025 it was -$268.58M. The highest annual figure on record is $602.91M in fiscal 2018.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$268.58M | – |
| FY2024 | Dec 31, 2024 | -$500.95M | – |
| FY2023 | Dec 31, 2023 | -$307.51M | – |
| FY2022 | Dec 31, 2022 | -$274.37M | -990.8% |
| FY2021 | Dec 31, 2021 | $30.80M | -14.2% |
| FY2020 | Dec 31, 2020 | $35.89M | -89.6% |
| FY2019 | Dec 31, 2019 | $345.63M | -42.7% |
| FY2018 | Dec 31, 2018 | $602.91M | +246.2% |
| FY2017 | Dec 31, 2017 | $174.15M | – |
| FY2016 | Dec 31, 2016 | -$112.11M | -630.7% |
| FY2015 | Dec 31, 2015 | $21.13M | +236.1% |
| FY2014 | Dec 31, 2014 | $6.29M | -90.1% |
| FY2013 | Dec 31, 2013 | $63.49M | +3284.5% |
| FY2012 | Dec 31, 2012 | $1.88M | – |
| FY2011 | Dec 31, 2011 | -$111.93M | – |
| FY2010 | Dec 31, 2010 | -$63.59M | – |
| FY2009 | Dec 31, 2009 | -$108.44M | -151.1% |
| FY2008 | Dec 31, 2008 | $212.03M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $565.53M | +273.7% |
| Q1 FY2026 | Mar 31, 2026 | -$792.82M | – |
| Q4 FY2025 | Dec 31, 2025 | -$137.71M | – |
| Q3 FY2025 | Sep 30, 2025 | -$131.44M | – |
| Q2 FY2025 | Jun 30, 2025 | $151.34M | – |
| Q1 FY2025 | Mar 31, 2025 | -$150.78M | – |
| Q4 FY2024 | Dec 31, 2024 | -$116.14M | -453.4% |
| Q3 FY2024 | Sep 30, 2024 | -$114.99M | – |
| Q2 FY2024 | Jun 30, 2024 | -$119.88M | – |
| Q1 FY2024 | Mar 31, 2024 | -$149.94M | – |
| Q4 FY2023 | Dec 31, 2023 | $32.87M | – |
| Q3 FY2023 | Sep 30, 2023 | -$109.02M | – |
| Q2 FY2023 | Jun 30, 2023 | -$97.36M | – |
| Q1 FY2023 | Mar 31, 2023 | -$133.99M | – |
| Q4 FY2022 | Dec 31, 2022 | -$200.20M | -198.3% |
| Q3 FY2022 | Sep 30, 2022 | -$24.43M | – |
| Q2 FY2022 | Jun 30, 2022 | -$18.10M | – |
| Q1 FY2022 | Mar 31, 2022 | -$31.65M | – |
| Q4 FY2021 | Dec 31, 2021 | $203.69M | +107.9% |
| Q3 FY2021 | Sep 30, 2021 | -$55.57M | – |
| Q2 FY2021 | Jun 30, 2021 | -$62.65M | – |
| Q1 FY2021 | Mar 31, 2021 | -$54.66M | – |
| Q4 FY2020 | Dec 31, 2020 | $97.98M | -64.7% |
| Q3 FY2020 | Sep 30, 2020 | -$10.28M | – |
| Q2 FY2020 | Jun 30, 2020 | -$44.22M | – |
| Q1 FY2020 | Mar 31, 2020 | -$7.59M | -107.0% |
| Q4 FY2019 | Dec 31, 2019 | $277.84M | +140.5% |
| Q3 FY2019 | Sep 30, 2019 | -$12.81M | – |
| Q2 FY2019 | Jun 30, 2019 | -$27.11M | -105.4% |
| Q1 FY2019 | Mar 31, 2019 | $107.71M | +718.1% |
| Q4 FY2018 | Dec 31, 2018 | $115.51M | +466.2% |
| Q3 FY2018 | Sep 30, 2018 | -$26.00M | -190.5% |
| Q2 FY2018 | Jun 30, 2018 | $500.24M | +21069.6% |
| Q1 FY2018 | Mar 31, 2018 | $13.17M | -89.3% |
| Q4 FY2017 | Dec 31, 2017 | $20.40M | – |
| Q3 FY2017 | Sep 30, 2017 | $28.72M | +18.3% |
| Q2 FY2017 | Jun 30, 2017 | $2.36M | – |
| Q1 FY2017 | Mar 31, 2017 | $122.67M | – |
| Q4 FY2016 | Dec 31, 2016 | -$26.84M | – |
| Q3 FY2016 | Sep 30, 2016 | $24.29M | – |
See a number that looks wrong?